Bain, UBS Lend $382 Million to Quadrant’s Aidacare in Australia

ArchivedSingle Source|1 articles|1 sources|1 blocks

Detected: Updated: Analyzed:

Finance Healthcare

Reported Facts

Observable data points shared across all narratives

•Bain Capital and UBS have lent a combined $382 million to Aidacare.
•Aidacare is a portfolio company of Quadrant Private Equity in Australia.
•The loan was announced on February 18, 2026.

What Could Happen If...

▸If Aidacare uses the loan to expand its healthcare services Aidacare's market share in the Australian healthcare sector could increase, benefiting Quadrant Private Equity's portfolio.

Market Exposure

StocksQuadrant Private Equity portfolio companiesUpward Pressure

If the loan enables Aidacare to grow, it could positively impact the valuation of Quadrant's healthcare assets.

This is not investment advice. Market exposure is based on conditional event analysis.

Key Actors

Countries

🌍Australia

Organizations

🏛Aidacare 🏛Bain Capital 🏛Quadrant Private Equity 🏛UBS Group AG

Source Coverage

FINANCE

1 articles

More coverage on this story

More on Australia
More on Aidacare
More on Bain Capital
More on Quadrant Private Equity

Signals

Single-block coverage

Primary Sources (1)

FINANCEBloomberg - MarketsBain, UBS Lend $382 Million to Quadrant’s Aidacare in Australia

Bain Capital and UBS have jointly provided a loan totaling $382 million to Aidacare, a company under Quadrant Private Equity in Australia. This financing deal is significant as it supports Aidacare's operations and potential expansion within the Australian healthcare sector. The involvement of major financial institutions like Bain and UBS underscores confidence in Aidacare's business model and the broader healthcare market in Australia. This transaction may also reflect ongoing investment trends in private equity-backed healthcare companies.